Furthermore, ELF-napsin A at nodule sites tended to rise according to increase in tumour size at surgery, suggesting that the expression of napsin A was greater with increased mass and secretory ability of primary lung adenocarcinoma, regardless of its histological subtype. The gene discussed is NAPSA; the disease is lung adenocarcinoma.